{"id":"NCT02635984","sponsor":"Augusta University","briefTitle":"Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens","officialTitle":"Randomized, Placebo Controlled Study of FOND (Fosaprepitant, Ondansetron, Dexamethasone) Versus FOND+O (FOND Plus Olanzapine) for the Prevention of Chemotherapy Induced Nausea and Vomiting in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11","primaryCompletion":"2017-12","completion":"2017-12","firstPosted":"2015-12-21","resultsPosted":"2018-08-20","lastUpdate":"2018-08-20"},"enrollment":108,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Complications of Bone Marrow Transplant","Hematologic Neoplasms"],"interventions":[{"type":"DRUG","name":"Olanzapine","otherNames":["Zyprexa"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Triplet Therapy Plus Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Triplet Therapy Plus Olanzapine","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of this study is to compare the effectiveness of olanzapine added to standard triplet therapy (fosaprepitant, ondansetron, and dexamethasone) versus triplet therapy alone in preventing chemotherapy-induced nausea and vomiting (CINV) in hematology patients receiving highly or moderately emetogenic chemotherapy regimens.","primaryOutcome":{"measure":"Overall Percentage of Patients Who Had a Complete Response","timeFrame":"Until study completion; estimated 1.5 years","effectByArm":[{"arm":"Triplet Therapy Plus Placebo","deltaMin":13,"sd":null},{"arm":"Triplet Therapy Plus Olanzapine","deltaMin":28,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.003"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":16,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["29906570"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":["Withdrawal From Study"]}}